Addex Therapeutics Ltd (APE) Stock Price & News

All values in CHF	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	36.38K	49.60K	15.83K	7.69K
Cost of goods sold	234.45K	228.32K	52.81K	36.13K
Cost of revenue	234.45K	228.32K	52.81K	36.13K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	534.82K	517.45K	742.28K	451.39K
Operating expense	534.82K	517.45K	742.28K	451.39K
Total operating expenses	769.27K	745.78K	795.09K	487.52K
Operating income	-732.90K	-696.18K	-779.26K	-479.83K
Other non operating income	-	-	-	-
EBT including unusual items	-1.96M	-1.58M	-1.83M	-1.71M
EBT excluding unusual items	-1.96M	-1.58M	-1.83M	-1.71M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-1.84M	-1.58M	-1.84M	-1.71M
Net profit margin	-5,061.62%	-3,179.90%	-11,604.47%	-22,256.39%
Earnings per share	-	-	-	-
Interest and investment income	3.00	-	-	-
Interest expense	-829.00	-472.00	-575.00	-956.00
Net interest expenses	-826.00	-472.00	-575.00	-956.00
Depreciation and amortization charges	-	-	-	-
EBITDA	-730.78K	-696.07K	-779.16K	-479.72K
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance